Hub / Organ Systems / Reproductive & Obstetrics

COMLEX Level 1 & 2-CE • USMLE Step 1 & 2-CK • Blueprint Weight: 9–12%

Reproductive & Obstetrics Command Center

Master menstrual endocrinology, VEAL CHOP fetal heart rate monitoring, third-trimester hemorrhage, preeclampsia diagnostic algorithms, ovarian and testicular neoplasms, breast pathology, and pelvic osteopathy.

Drill Repro Qbank

Histological phases of the human endometrium: proliferative straight tubular glands vs secretory tortuous saw-tooth glands

Endometrial Histology: Proliferative phase (straight tubular glands, abundant mitoses) vs. Secretory phase (coiled/tortuous saw-tooth glands with subnuclear glycogen vacuoles).

Hormonal Dynamics of the 28-Day Menstrual Cycle

The menstrual cycle is regulated by the hypothalamic-pituitary-ovarian (HPO) axis. Pulsatile GnRH stimulates FSH and LH release, governing two distinct ovarian and endometrial phases:

Follicular (Proliferative) Phase: Days 1–14

FSH stimulates granulosa cell aromatase (converts theca cell androstenedione into estradiol). Rising estradiol proliferates the endometrium. At high sustained concentrations (>200 pg/mL for 48 hrs), estrogen switches from negative to positive feedback on the pituitary, triggering the LH surge → Ovulation at Day 14.

Luteal (Secretory) Phase: Days 15–28

Ruptured follicle transforms into the corpus luteum, secreting copious progesterone (and estrogen). Progesterone stabilizes the endometrium, halts mitoses, induces gland tortuosity, and promotes secretion. In absence of hCG, corpus luteum degenerates into corpus albicans → abrupt progesterone withdrawal triggers menstruation.

Master Amenorrhea Diagnostic Algorithm

Step 1 in ANY patient with amenorrhea is Urine / Serum β-hCG to rule out pregnancy. If negative, evaluate TSH, Prolactin, and FSH.

Disorder	Karyotype & Phenotype	Uterus & Ovaries	FSH / LH / Hormones	Distinguishing Board Clues
Turner Syndrome	45,XO (Female)	Uterus present; Streak ovaries (fibrous tissue)	Markedly elevated FSH & LH (hypergonadotropic hypogonadism)	Short stature, webbed neck (cystic hygroma), coarctation of aorta, bicuspid aortic valve, horseshoe kidney
Kallmann Syndrome	46,XX or 46,XY	Hypoplastic internal organs	Low/undetectable GnRH, FSH, and LH (hypogonadotropic)	Failure of GnRH neurons to migrate from olfactory placode; Anosmia (inability to smell)
Müllerian Agenesis (Mayer-Rokitansky-Küster-Hauser)	46,XX (Normal female)	Absent uterus & upper 2/3 vagina; Normal functional ovaries	NORMAL estrogen, progesterone, FSH, and LH	Normal breast development & normal pubic/axillary hair (functioning ovaries); blind vaginal pouch; renal anomalies
Androgen Insensitivity Syndrome (AIS)	46,XY (Genotypic male, phenotypic female)	Absent uterus & ovaries; Cryptorchid testes present	High testosterone, high LH, normal/elevated estrogen	Normal breast development (peripheral aromatization), but SCANT or ABSENT pubic/axillary hair; remove testes after puberty (malignancy risk)
Polycystic Ovary Syndrome (PCOS)	46,XX (Female)	Bilateral enlarged ovaries with subcapsular follicular cysts	LH:FSH ratio > 2:1, elevated androgens, insulin resistance	Oligomenorrhea, hirsutism, acne, obesity, acanthosis nigricans. Increased risk of endometrial hyperplasia/cancer from unopposed estrogen

VEAL CHOP Fetal Heart Rate Monitoring Tracings

Cardiotocography Guide: Deceleration timing relative to uterine contractions determines fetal physiology and hypoxia risk.

VEAL CHOP Fetal Heart Rate Decelerations

Continuous intrapartum electronic fetal monitoring assesses fetal oxygenation and autonomic reserve. Memorize the high-yield VEAL CHOP alignment:

V = Variable Decelerations C = Cord Compression

Abrupt drop (<30 sec to nadir) with sharp V or U shape, unrelated to contractions. Umbilical cord compression stimulates vagal response. Rx: Maternal repositioning (lateral decubitus), amnioinfusion if oligohydramnios.

E = Early Decelerations H = Head Compression

Gradual deceleration (≥30 sec to nadir) that mirrors uterine contraction (nadir aligns with contraction peak). Fetal head compression triggers benign vagal baroreflex. Normal physiologic finding; no intervention needed.

A = Accelerations O = OK / Oxygenated

Abrupt increase in FHR ≥15 bpm above baseline lasting ≥15 seconds (15x15 rule in >32 weeks). Reassuring sign of fetal well-being, intact sympathetic drive, and absence of acidosis.

L = Late Decelerations P = Placental Insufficiency

Gradual deceleration (≥30 sec to nadir) with nadir occurring AFTER the contraction peak. Indicates uteroplacental insufficiency, hypoxia, and lactic acidosis. Emergency: 100% O2, IV fluids, stop oxytocin, prepare for emergent operative delivery.

Third-Trimester Vaginal Bleeding Differential

Condition	Pain & Uterine Tone	Bleeding Characteristics	Fetal Status	Diagnostic & Management Pearl
Placenta Previa	Painless; soft, non-tender uterus	Bright red vaginal bleeding	Usually reassuring initially	NEVER PERFORM DIGITAL CERVICAL EXAM! Perform transabdominal/transvaginal ultrasound. C-section delivery indicated.
Placental Abruption (Abruptio Placentae)	Severe abdominal pain; rigid, hypertonic ("woody") uterus	Dark red blood (or concealed behind retroplacental hematoma)	Fetal distress, late decelerations, fetal demise	Risk factors: HTN, preeclampsia, cocaine, trauma, smoking. High risk of DIC due to massive tissue factor release into maternal circulation.
Uterine Rupture	Sudden tearing abdominal pain; cessation of contractions	Variable vaginal bleeding	Severe bradycardia; loss of fetal station	#1 risk factor is prior uterine surgery (classic vertical C-section scar). Fetus may extrude into peritoneal cavity. Emergent laparotomy and delivery.
Vasa Previa	Painless; soft non-tender uterus	Rapid onset of bleeding immediately upon rupture of membranes	Rapid profound fetal bradycardia & death	Fetal vessels cross internal os unprotected by Wharton jelly. Blood is FETAL in origin. Apt test confirms fetal hemoglobin (alkali-resistant).

Clinical Diagnostic Matrix > 20 Weeks Gestation

Preeclampsia diagnostic criteria algorithm: hypertension, proteinuria, and severe end-organ features

Hypertensive Disorders of Pregnancy

New-onset systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg after 20 weeks gestation. Abnormal spiral artery remodeling leads to placental ischemia, widespread maternal endothelial dysfunction, and end-organ injury.

Severe Features: BP ≥160/110, platelets <100,000, AST/ALT >2x ULN, serum Cr >1.1 mg/dL, pulmonary edema, or new intractable headache / visual scotomata.

Pelvic Ultrasound & Gross Snowstorm Appearance

Ultrasound of complete hydatidiform mole showing classic snowstorm pattern and gross grapes appearance

Gestational Trophoblastic Disease

Proliferation of placental trophoblast tissue. Presents with painless first-trimester vaginal bleeding, uterine size > gestational age, severe hyperemesis gravidarum, and theca-lutein cysts.

Complete vs. Partial Mole: Complete (46,XX, paternal only, enucleated egg, no embryo, β-hCG >> 100,000 mIU/mL, highest risk of choriocarcinoma) vs. Partial (69,XXY, 2 sperm + 1 egg, fetal parts present, normal/mildly elevated β-hCG).

Choriocarcinoma histology displaying sheets of malignant cytotrophoblasts and syncytiotrophoblasts without chorionic villi

Choriocarcinoma: Sheets of syncytiotrophoblasts and cytotrophoblasts with extensive hemorrhage and necrosis; NO chorionic villi present.

Choriocarcinoma & HELLP Syndrome

HELLP Syndrome

Severe variant of preeclampsia: Hemolysis (MAHA, schistocytes on blood smear, indirect hyperbilirubinemia, low haptoglobin), Elevated Liver enzymes (AST/ALT > 2x ULN), and Low Platelets (<100,000/μL). Complications: Hepatic subcapsular hematoma rupture and DIC. Immediate delivery indicated.

Eclampsia & Seizure Prophylaxis

New-onset grand mal seizures in a patient with preeclampsia. Drug of choice: IV Magnesium Sulfate (therapeutic level: 4–7 mEq/L). Monitor patellar reflexes, respiratory rate, and urine output. Reversal agent for magnesium toxicity (loss of DTRs, respiratory depression) is IV Calcium Gluconate.

Ovarian Neoplasms: Epithelial, Germ Cell & Sex-Cord Stromal

Granulosa Cell Tumor

Sex cord-stromal tumor producing estrogen. Postmenopausal bleeding or precocious puberty in young girls. Histology: Small follicles filled with eosinophilic fluid (Call-Exner bodies) and "coffee-bean" nuclei. Inhibin tumor marker.

Schiller-Duval body resembling a primitive glomerulus in yolk sac tumor

Yolk Sac (Endodermal Sinus) Tumor

Malignant germ cell tumor in children/young women. Secretes α-fetoprotein (AFP). Histology: Schiller-Duval bodies consisting of a central blood vessel surrounded by germ cells within a cystic space (resembling a primitive renal glomerulus).

Serous Cystadenocarcinoma

Most common malignant ovarian neoplasm; frequently bilateral. Associated with BRCA1/BRCA2 mutations. Monitored with CA-125 marker. Histology: Papillary projections with concentric lamellated calcifications (Psammoma bodies).

Gross ovarian endometriosis showing chocolate cyst filled with dark brown degraded blood

Endometriosis & Endometrioma

Ectopic non-neoplastic endometrial glands and stroma outside uterus (most commonly ovary, uterosacral ligaments). Cyclic bleeding creates "chocolate cysts" in ovaries. Triad: Dysmenorrhea, Dyspareunia, and Infertility with a retroverted fixed uterus.

Uterine leiomyoma histology showing whorled fascicles of uniform smooth muscle cells

Uterine Leiomyoma (Fibroid)

Most common benign pelvic tumor in females; highest incidence in African-American women. Estrogen-sensitive (expands during pregnancy, regresses post-menopause). Histology: Distinct whorled bundles of smooth muscle cells. Causes heavy menorrhagia and iron deficiency anemia.

Cervical & Endometrial Malignancies

Cervical cytology Pap smear demonstrating HPV-induced koilocytes with perinuclear halos and hyperchromatic raisinoid nuclei

HPV Koilocytic Atypia

Pathognomonic for HPV infection (high-risk strains 16 & 18). Pap smear exhibits koilocytes: enlarged squamous epithelial cells with hyperchromatic "raisinoid" nuclei surrounded by prominent perinuclear halos.

Cervical squamous cell carcinoma biopsy showing nests of malignant cells invading the stroma

Cervical Carcinoma

High-risk HPV oncogenes: E6 (promotes p53 degradation) and E7 (promotes Rb phosphorylation/inhibition). Infiltrates transformation zone; lateral extension can obstruct ureters, causing post-renal AKI and hydronephrosis (leading cause of death).

Endometrial Adenocarcinoma

Driven by unopposed estrogen (obesity, nulliparity, tamoxifen, early menarche/late menopause, PCOS). Classic presentation: postmenopausal vaginal bleeding. Requires prompt endometrial biopsy to rule out malignancy.

Master Breast Pathology Matrix

Lesion	Malignancy Risk	Demographic & Presentation	Characteristic Histology	High-Yield Clinical Clue
Fibroadenoma	Benign (no increased cancer risk)	Young females (<35yo); firm, mobile, well-circumscribed marble mass	Cellular stromal proliferation compressing slit-like glandular epithelium	Estrogen-sensitive (grows/tender in pregnancy & late luteal phase)
Intraductal Papilloma	Benign (slight risk if multiple)	Pre- or post-menopausal female	Fibrovascular core lined by luminal and myoepithelial cells	#1 cause of unilateral bloody or serosanguinous nipple discharge
Invasive Ductal Carcinoma (IDC)	Malignant (75–80% of all breast cancers)	Postmenopausal female; hard, fixed, irregular painless mass; nipple retraction	Malignant ductal cells forming nests/tubules in dense collagenous stroma ("scirrhous" response)	Stellate, spiculated mass with microcalcifications on mammography
Invasive Lobular Carcinoma (ILC)	Malignant (frequently bilateral/multifocal)	Postmenopausal female; subtle palpable mass	Single-file "Indian file" linear cords of cells due to loss of E-cadherin	Mutation / loss of CDH1 gene (E-cadherin adhesion molecule)
Inflammatory Breast Cancer	Malignant (extremely aggressive, poor prognosis)	Warm, erythematous, swollen breast with thickened orange-peel skin	Dermal lymphatic invasion by tumor emboli blocking lymphatic drainage	Peau d'orange appearance; often misdiagnosed as acute mastitis

Testicular seminoma histology with uniform fried-egg cells and lymphocytic fibrous septa

Testicular Seminoma: Large uniform cells with clear glycogen-rich cytoplasm ("fried-egg" appearance) traversed by fibrous septa containing lymphocytes.

Testicular Neoplasms & Diagnostic Protocol

Presents in young men (15–35yo) as a painless testicular mass that does NOT transilluminate (unlike a hydrocele or spermatocele).

Mandatory Board Protocol: NEVER PERFORM A TRANS-SCROTAL BIOPSY! Biopsying through the scrotum disrupts lymphatic drainage and seeds malignant cells into superficial inguinal nodes. Diagnosis and treatment require Radical Inguinal Orchiectomy (retroperitoneal lymph nodes drain testes).

Seminoma (50% of Germ Cell)

Fried-egg appearance with watery clear cytoplasm, round nuclei, prominent nucleoli, and dense lymphocytic infiltrate. Radiosensitive with >95% cure rate. Placental alkaline phosphatase (PLAP)+, rarely β-hCG.

Non-Seminomatous Tumors

Embryonal carcinoma (painful, hemorrhagic, necrosis), Yolk sac (Schiller-Duval, high AFP), Choriocarcinoma (high β-hCG → gynecomastia/hyperthyroidism, hematogenous spread to lungs/brain), and Teratoma (malignant in adult males).

Prostate Pathology: BPH vs. Adenocarcinoma

Benign Prostatic Hyperplasia (BPH)

Transition Zone

Hyperplasia of glandular and stromal elements driven by dihydrotestosterone (DHT) synthesized from testosterone via 5α-reductase type 2.

Location: Transitional (periurethral) zone, compressing the prostatic urethra.
Symptoms: Hesitancy, weak urinary stream, post-void dribbling, nocturia, urinary urgency.
Exam: Smooth, elastic, symmetrically enlarged non-tender prostate.
Pharmacotherapy:
• α1-blockers (Tamsulosin, Doxazosin): Relaxes smooth muscle; rapid symptom relief.
• 5α-reductase inhibitors (Finasteride): Blocks DHT synthesis, shrinking prostate volume over 6–12 months.

Prostate Adenocarcinoma

Peripheral Zone

Most common non-skin malignancy in men. Arises in the posterior lobe and peripheral gland, so urinary symptoms are typically ABSENT until advanced stages.

Location: Peripheral zone (easily palpated on digital rectal exam).
DRE Findings: Hard, nodular, asymmetric, irregular prostate gland.
Tumor Marker: Elevated serum PSA (>4 ng/mL; decreased percent free PSA).
Bone Metastasis: Spreads via Batson venous plexus to lumbar spine and pelvis, producing classic osteoblastic (sclerotic) lesions with markedly elevated alkaline phosphatase (ALP).
Grading: Gleason score based entirely on architectural pattern, not cytologic atypia.

Interactive Board Simulation & Case Solver

High-yield board vignettes testing third-trimester hemorrhage, FHR tracings, preeclampsia, ovarian neoplasms, and pelvic osteopathy.

Case Vignette 1 • Third-Trimester Bleeding COMLEX / USMLE Item

A 32-year-old G3P2 female at 34 weeks of gestation presents to the labor and delivery triage with sudden, painless, bright red vaginal bleeding that soaked two sanitary pads over the past hour. She reports active fetal movements and denies abdominal pain, contractions, or leakage of fluid. Her temperature is 36.8°C, blood pressure is 118/74 mmHg, and heart rate is 78/min. On physical examination, her abdomen is soft, non-tender, and non-distended without palpable uterine contractions.

What is the most appropriate next step in the clinical management of this patient?

A. Emergent digital vaginal examination to assess cervical dilation
B. Transabdominal ultrasonography
C. Immediate administration of intravenous oxytocin
D. Urgent amniotomy (artificial rupture of membranes)
E. Diagnostic culdocentesis

Case Vignette 2 • Obstetric Critical Care Preeclampsia with Severe Features

A 24-year-old primigravida female at 35 weeks gestation presents to the emergency department complaining of an excruciating frontal headache and blurry vision with flashing lights that began 6 hours ago. Her blood pressure is 172/114 mmHg on two readings taken 15 minutes apart. Urinalysis reveals 3+ protein. Laboratory evaluation reveals platelets of 84,000/μL, AST of 128 U/L, ALT of 142 U/L, and serum creatinine of 1.3 mg/dL.

In addition to initiating urgent antihypertensive therapy and planning delivery, which pharmacologic agent is most immediately indicated to prevent maternal mortality?

A. Intravenous Diazepam
B. Intravenous Phenytoin
C. Intravenous Magnesium Sulfate
D. Oral Levetiracetam
E. Intramuscular Betamethasone alone

Case Vignette 3 • Intrapartum Cardiotocography Fetal Monitoring

A 28-year-old female at 39 weeks gestation is in active labor at 6 cm cervical dilation. The external fetal heart rate tracing demonstrates a baseline rate of 140 bpm with moderate variability. With each contraction, there is a gradual decrease in fetal heart rate beginning approximately 30 seconds after the contraction starts, with the nadir of the deceleration occurring 20 seconds after the peak of the contraction, returning to baseline only after the contraction has fully resolved.

What is the underlying pathophysiological mechanism of this fetal heart rate pattern?

A. Compression of the fetal head during passage through the birth canal
B. Acute compression of the umbilical cord vessels
C. Uteroplacental insufficiency with fetal hypoxia and chemoreceptor activation
D. Physiologic fetal response to maternal movement
E. Complete fetal atrioventricular nodal heart block

Case Vignette 4 • Gynecologic Oncology Ovarian Pathology

A 61-year-old postmenopausal female presents to her gynecologist with intermittent vaginal spotting over the past two months. She underwent menopause 10 years ago. Pelvic ultrasound reveals a 6.5-cm complex solid and cystic mass in the left adnexa and an endometrial stripe measuring 14 mm (normal postmenopausal ≤4 mm). Endometrial biopsy confirms simple endometrial hyperplasia without atypia. Following left salpingo-oophorectomy, histological examination of the ovarian mass demonstrates microfollicular structures containing eosinophilic fluid with grooved, coffee-bean nuclei.

What is the most likely diagnosis?

A. Serous cystadenocarcinoma
B. Granulosa cell tumor
C. Dysgerminoma
D. Mature cystic teratoma
E. Yolk sac tumor

Case Vignette 5 • Male Reproductive & Surgical Oncology Urology Emergency

A 26-year-old previously healthy male discovers a painless lump in his right testicle while showering. He has no urinary frequency, dysuria, hematuria, or urethral discharge. On physical examination, a firm, non-tender, 2.5-cm mass is palpated within the body of the right testicle. The mass does not transilluminate with a penlight. Scrotal ultrasound reveals a homogeneous, hypoechoic intratesticular mass. Serum α-fetoprotein (AFP) is normal, and serum β-hCG is minimally elevated at 18 mIU/mL.

What is the most appropriate next step in surgical management?

A. Trans-scrotal percutaneous core needle biopsy
B. Fine-needle aspiration through the scrotal sac
C. Radical inguinal orchiectomy
D. Watchful waiting with repeat ultrasound in 3 months
E. Transurethral resection of the prostate